In Europe, a mere 30% of marketed drugs have pediatric approval, and less than half of children’s commonly used medicines are properly tested for them. This forces healthcare providers to use off-label or unauthorized drugs, risking inefficacy and adverse reactions, putting children at greater risk of medication errors than adults.